Article

Non-Invasive Urine-Based Diagnostic Technologies for Early Bladder Cancer

2026-01-21

Abstract excerpt

Bladder cancer (BCa) is a major global urinary tract malignancy characterized by high incidence, frequent recurrence, and significant mortality. Early diagnosis is crucial for improving prognosis and minimizing invasive procedures; however, current standard techniques, cystoscopy and urine cytology, are limited by invasiveness, cost, low sensitivity, and subjectivity. This has spurred the development of non‑invasi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1d3e0412-ab17-54b6-b1d4-83f88b8532b8
DOI: 10.20944/preprints202601.1618.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Non-Invasive Urine-Based Diagnostic Technologies for Early Bladder CancerDOI 10.20944/preprints202601.1618.v1Read

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read

Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkersSemantic proximity Read

Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAsSemantic proximity Read

Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?Semantic proximity Read

Advances in Urinary Biomarkers for the Early Detection of Urological Cancers: From Proteins and Epigenetics to Gene Mutations.Semantic proximity Read

Urinary Biomarkers in Urothelial Carcinoma: Expanded Con-temporary Evidence for Diagnosis, Surveillance, Risk Stratification, and Cystoscopy-Sparing Clinical PathwaysSemantic proximity Read

Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer ManagementSemantic proximity Read

A systematic review on diagnostic and prognostic biomarkers for bladder cancerSemantic proximity Read

Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder CancerSemantic proximity Read

Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence.Semantic proximity Read

EarlyTect BCD, a Streamlined PENK Methylation Test in Urine DNA, Effectively Detects Bladder Cancer in Patients with HematuriaSemantic proximity Read

Bladder cancer detection in urine by novel methylation markersSemantic proximity Read